Vmp-like sequences of pathogenic Borrelia
US-9212218-B2 · Dec 15, 2015 · US
Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
US9241983B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9241983-B2 |
| Application number | US-201214114703-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 30, 2012 |
| Priority date | Apr 29, 2011 |
| Publication date | Jan 26, 2016 |
| Grant date | Jan 26, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention encompasses methods and compositions for Ureaplasma infection prevention and/or treatment. In specific cases, the invention concerns vaccines for Ureaplasma , including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of Ureaplasma.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of inhibiting or reducing symptoms of Ureaplasma infection in an individual, comprising the step of delivering to the individual a therapeutically effective amount of antibodies that recognize the conserved region of Ureaplasma multiple-banded antigen or the 5′ end of the multiple-banded antigen. 2. The method of claim 1 , further comprising multiple steps of delivering antibodies to the individual. 3. The method of claim 2 , wherein the multiple deliveries are separated by one month or more. 4. The method of claim 2 , wherein the multiple deliveries are separated by days or weeks. 5. The method of claim 2 , wherein the multiple deliveries are separated by one year, two years, or ten years. 6. The method of claim 1 , wherein the delivery is into the amniotic cavity. 7. The method of claim 1 , wherein the delivery of antibodies is vaginally administered. 8. The method of claim 1 , wherein the individual is a female or male prior to a first sexual activity. 9. The method of claim 1 , wherein the individual is a female prior to pregnancy. 10. The method of claim 1 , wherein the individual is a pregnant female. 11. The method of claim 1 , wherein the antibodies recognize the 5′ end of the Ureaplasma multiple-banded antigen. 12. The method of claim 1 , wherein the antibodies recognize the Ureaplasma sequence of SEQ ID No: 4. 13. The method of claim 1 , wherein the individual is of one of the species human, cow, dog, cat, horse, pig, goat, sheep, or bird.
Assignees
Inventors
Classifications
Detection of antigens from microorganism in sample from host · CPC title
from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO] · CPC title
DNA (RNA) vaccination · CPC title
- A61K39/02Primary
Bacterial antigens · CPC title
from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO] · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9241983B2 cover?
- The present invention encompasses methods and compositions for Ureaplasma infection prevention and/or treatment. In specific cases, the invention concerns vaccines for Ureaplasma , including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of Ureaplasma.
- Who is the assignee on this patent?
- Weisman Leonard, Kong Lingkun, Baylor College Medicine
- What technology area does this patent fall under?
- Primary CPC classification A61K39/02. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).